nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—CYP1B1—Progesterone—uterine cancer	0.17	0.255	CbGbCtD
Theophylline—CYP1A1—Progesterone—uterine cancer	0.0746	0.112	CbGbCtD
Theophylline—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.065	0.0976	CbGbCtD
Theophylline—CYP1B1—Doxorubicin—uterine cancer	0.0519	0.0779	CbGbCtD
Theophylline—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0453	0.0681	CbGbCtD
Theophylline—CYP2C8—Progesterone—uterine cancer	0.0431	0.0646	CbGbCtD
Theophylline—CYP1A2—Progesterone—uterine cancer	0.0333	0.05	CbGbCtD
Theophylline—CYP2C9—Progesterone—uterine cancer	0.03	0.0451	CbGbCtD
Theophylline—CYP2D6—Progesterone—uterine cancer	0.0275	0.0412	CbGbCtD
Theophylline—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0264	0.0396	CbGbCtD
Theophylline—CYP2E1—Etoposide—uterine cancer	0.0258	0.0387	CbGbCtD
Theophylline—CYP2C8—Etoposide—uterine cancer	0.0193	0.0289	CbGbCtD
Theophylline—CYP3A4—Progesterone—uterine cancer	0.0175	0.0262	CbGbCtD
Theophylline—CYP1A2—Etoposide—uterine cancer	0.0149	0.0224	CbGbCtD
Theophylline—CYP2D6—Doxorubicin—uterine cancer	0.00838	0.0126	CbGbCtD
Theophylline—CYP3A4—Etoposide—uterine cancer	0.00781	0.0117	CbGbCtD
Theophylline—Venous thrombosis—Carboplatin—uterine cancer	0.00614	0.0528	CcSEcCtD
Theophylline—HDAC2—oviduct—uterine cancer	0.00595	0.0605	CbGeAlD
Theophylline—Fluid overload—Carboplatin—uterine cancer	0.00533	0.0459	CcSEcCtD
Theophylline—CYP3A4—Doxorubicin—uterine cancer	0.00533	0.008	CbGbCtD
Theophylline—PDE5A—artery—uterine cancer	0.00421	0.0428	CbGeAlD
Theophylline—Caffeine—PIK3CA—uterine cancer	0.00392	1	CrCbGaD
Theophylline—Extravasation—Carboplatin—uterine cancer	0.0038	0.0327	CcSEcCtD
Theophylline—HDAC2—exocrine gland—uterine cancer	0.00344	0.0349	CbGeAlD
Theophylline—Venous thrombosis—Medroxyprogesterone Acetate—uterine cancer	0.00292	0.0252	CcSEcCtD
Theophylline—Phlebitis—Carboplatin—uterine cancer	0.00279	0.024	CcSEcCtD
Theophylline—ADA—myometrium—uterine cancer	0.00246	0.025	CbGeAlD
Theophylline—HDAC2—Teniposide—Etoposide—uterine cancer	0.00245	0.731	CbGdCrCtD
Theophylline—Supraventricular tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00241	0.0207	CcSEcCtD
Theophylline—Hypercalcaemia—Medroxyprogesterone Acetate—uterine cancer	0.00227	0.0195	CcSEcCtD
Theophylline—ADORA2B—smooth muscle tissue—uterine cancer	0.00203	0.0206	CbGeAlD
Theophylline—ADORA2B—decidua—uterine cancer	0.00199	0.0202	CbGeAlD
Theophylline—ADORA2B—mammalian vulva—uterine cancer	0.00183	0.0186	CbGeAlD
Theophylline—ADA—decidua—uterine cancer	0.00182	0.0185	CbGeAlD
Theophylline—ADA—renal system—uterine cancer	0.00179	0.0182	CbGeAlD
Theophylline—PDE4A—decidua—uterine cancer	0.00177	0.018	CbGeAlD
Theophylline—ADA—mammalian vulva—uterine cancer	0.00167	0.017	CbGeAlD
Theophylline—SLC22A7—renal system—uterine cancer	0.00161	0.0164	CbGeAlD
Theophylline—PDE5A—epithelium—uterine cancer	0.0016	0.0162	CbGeAlD
Theophylline—PDE5A—uterine cervix—uterine cancer	0.00158	0.0161	CbGeAlD
Theophylline—PDE5A—smooth muscle tissue—uterine cancer	0.00154	0.0156	CbGeAlD
Theophylline—PDE3A—smooth muscle tissue—uterine cancer	0.0015	0.0152	CbGeAlD
Theophylline—HDAC2—epithelium—uterine cancer	0.0015	0.0152	CbGeAlD
Theophylline—HDAC2—uterine cervix—uterine cancer	0.00148	0.0151	CbGeAlD
Theophylline—PDE5A—renal system—uterine cancer	0.00148	0.0151	CbGeAlD
Theophylline—HDAC2—smooth muscle tissue—uterine cancer	0.00144	0.0146	CbGeAlD
Theophylline—PDE4D—female gonad—uterine cancer	0.00143	0.0146	CbGeAlD
Theophylline—ADA—female reproductive system—uterine cancer	0.00143	0.0145	CbGeAlD
Theophylline—ADORA2B—vagina—uterine cancer	0.00142	0.0144	CbGeAlD
Theophylline—Disorientation—Progesterone—uterine cancer	0.00141	0.0122	CcSEcCtD
Theophylline—HDAC2—decidua—uterine cancer	0.00141	0.0144	CbGeAlD
Theophylline—Extravasation—Dactinomycin—uterine cancer	0.00141	0.0121	CcSEcCtD
Theophylline—ADORA1—renal system—uterine cancer	0.0014	0.0143	CbGeAlD
Theophylline—HDAC2—renal system—uterine cancer	0.00139	0.0141	CbGeAlD
Theophylline—HDAC2—endometrium—uterine cancer	0.00134	0.0136	CbGeAlD
Theophylline—Anaphylactoid reaction—Progesterone—uterine cancer	0.00131	0.0112	CcSEcCtD
Theophylline—ADORA2A—female reproductive system—uterine cancer	0.0013	0.0132	CbGeAlD
Theophylline—ADA—vagina—uterine cancer	0.00129	0.0132	CbGeAlD
Theophylline—PDE4A—female gonad—uterine cancer	0.00127	0.0129	CbGeAlD
Theophylline—Sinus tachycardia—Epirubicin—uterine cancer	0.00124	0.0107	CcSEcCtD
Theophylline—HDAC2—uterus—uterine cancer	0.00124	0.0126	CbGeAlD
Theophylline—Irritability—Progesterone—uterine cancer	0.00121	0.0104	CcSEcCtD
Theophylline—PDE5A—female reproductive system—uterine cancer	0.00119	0.0121	CbGeAlD
Theophylline—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.0102	CcSEcCtD
Theophylline—Infection—Carboplatin—uterine cancer	0.00118	0.0101	CcSEcCtD
Theophylline—PDE3A—female reproductive system—uterine cancer	0.00115	0.0117	CbGeAlD
Theophylline—Sinus tachycardia—Doxorubicin—uterine cancer	0.00115	0.00987	CcSEcCtD
Theophylline—ADORA1—female reproductive system—uterine cancer	0.00112	0.0114	CbGeAlD
Theophylline—HDAC2—female reproductive system—uterine cancer	0.00111	0.0113	CbGeAlD
Theophylline—PDE4B—uterine cervix—uterine cancer	0.00111	0.0113	CbGeAlD
Theophylline—PDE3B—lymph node—uterine cancer	0.00111	0.0112	CbGeAlD
Theophylline—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00941	CcSEcCtD
Theophylline—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00937	CcSEcCtD
Theophylline—PDE5A—female gonad—uterine cancer	0.00108	0.011	CbGeAlD
Theophylline—PDE5A—vagina—uterine cancer	0.00107	0.0109	CbGeAlD
Theophylline—PDE4B—decidua—uterine cancer	0.00106	0.0107	CbGeAlD
Theophylline—PDE3A—female gonad—uterine cancer	0.00105	0.0107	CbGeAlD
Theophylline—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00897	CcSEcCtD
Theophylline—Phlebitis—Dactinomycin—uterine cancer	0.00104	0.00892	CcSEcCtD
Theophylline—Extravasation—Etoposide—uterine cancer	0.00102	0.00878	CcSEcCtD
Theophylline—ADORA1—vagina—uterine cancer	0.00102	0.0103	CbGeAlD
Theophylline—HDAC2—female gonad—uterine cancer	0.00101	0.0103	CbGeAlD
Theophylline—HDAC2—vagina—uterine cancer	0.001	0.0102	CbGeAlD
Theophylline—PDE4B—endometrium—uterine cancer	0.001	0.0102	CbGeAlD
Theophylline—Hyperglycaemia—Progesterone—uterine cancer	0.000986	0.00848	CcSEcCtD
Theophylline—PDE4B—mammalian vulva—uterine cancer	0.000971	0.00987	CbGeAlD
Theophylline—Hyperuricaemia—Etoposide—uterine cancer	0.000961	0.00826	CcSEcCtD
Theophylline—Body temperature increased—Carboplatin—uterine cancer	0.000935	0.00804	CcSEcCtD
Theophylline—Venous thrombosis—Epirubicin—uterine cancer	0.000926	0.00796	CcSEcCtD
Theophylline—CYP1B1—smooth muscle tissue—uterine cancer	0.000925	0.0094	CbGeAlD
Theophylline—PDE4D—lymph node—uterine cancer	0.000922	0.00937	CbGeAlD
Theophylline—Blood uric acid increased—Etoposide—uterine cancer	0.000908	0.0078	CcSEcCtD
Theophylline—CYP1B1—decidua—uterine cancer	0.000907	0.00921	CbGeAlD
Theophylline—HDAC2—Levonorgestrel—Progesterone—uterine cancer	0.000903	0.269	CbGdCrCtD
Theophylline—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.000893	0.00768	CcSEcCtD
Theophylline—CYP1B1—renal system—uterine cancer	0.00089	0.00905	CbGeAlD
Theophylline—Venous thrombosis—Doxorubicin—uterine cancer	0.000856	0.00736	CcSEcCtD
Theophylline—ADA—lymph node—uterine cancer	0.000838	0.00851	CbGeAlD
Theophylline—PDE4B—female reproductive system—uterine cancer	0.000832	0.00845	CbGeAlD
Theophylline—PDE4A—lymph node—uterine cancer	0.000816	0.00829	CbGeAlD
Theophylline—CYP1B1—uterus—uterine cancer	0.000793	0.00806	CbGeAlD
Theophylline—Alopecia—Progesterone—uterine cancer	0.000773	0.00665	CcSEcCtD
Theophylline—PDE4B—female gonad—uterine cancer	0.000757	0.00769	CbGeAlD
Theophylline—PDE4B—vagina—uterine cancer	0.000752	0.00765	CbGeAlD
Theophylline—Phlebitis—Etoposide—uterine cancer	0.000751	0.00646	CcSEcCtD
Theophylline—Tension—Progesterone—uterine cancer	0.000747	0.00643	CcSEcCtD
Theophylline—Nervousness—Progesterone—uterine cancer	0.00074	0.00636	CcSEcCtD
Theophylline—Hypercalcaemia—Epirubicin—uterine cancer	0.000719	0.00618	CcSEcCtD
Theophylline—Haematemesis—Epirubicin—uterine cancer	0.000719	0.00618	CcSEcCtD
Theophylline—Tremor—Progesterone—uterine cancer	0.000714	0.00614	CcSEcCtD
Theophylline—CYP1B1—female reproductive system—uterine cancer	0.000713	0.00724	CbGeAlD
Theophylline—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000701	0.00602	CcSEcCtD
Theophylline—PDE5A—lymph node—uterine cancer	0.000694	0.00705	CbGeAlD
Theophylline—CYP2C8—renal system—uterine cancer	0.000682	0.00693	CbGeAlD
Theophylline—CYP1A1—epithelium—uterine cancer	0.000678	0.00689	CbGeAlD
Theophylline—Tension—Medroxyprogesterone Acetate—uterine cancer	0.000677	0.00582	CcSEcCtD
Theophylline—PDE3A—lymph node—uterine cancer	0.000675	0.00686	CbGeAlD
Theophylline—Ventricular arrhythmia—Epirubicin—uterine cancer	0.000675	0.0058	CcSEcCtD
Theophylline—Palpitations—Progesterone—uterine cancer	0.000673	0.00579	CcSEcCtD
Theophylline—CYP1A1—uterine cervix—uterine cancer	0.000673	0.00684	CbGeAlD
Theophylline—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00067	0.00576	CcSEcCtD
Theophylline—Albuminuria—Epirubicin—uterine cancer	0.000669	0.00575	CcSEcCtD
Theophylline—Anaphylactoid reaction—Etoposide—uterine cancer	0.000668	0.00575	CcSEcCtD
Theophylline—Haematemesis—Doxorubicin—uterine cancer	0.000665	0.00572	CcSEcCtD
Theophylline—Hypercalcaemia—Doxorubicin—uterine cancer	0.000665	0.00572	CcSEcCtD
Theophylline—Convulsion—Progesterone—uterine cancer	0.00066	0.00567	CcSEcCtD
Theophylline—CYP2C8—endometrium—uterine cancer	0.000659	0.0067	CbGeAlD
Theophylline—ADORA1—lymph node—uterine cancer	0.000658	0.00669	CbGeAlD
Theophylline—HDAC2—lymph node—uterine cancer	0.00065	0.0066	CbGeAlD
Theophylline—CYP1B1—female gonad—uterine cancer	0.000649	0.00659	CbGeAlD
Theophylline—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000647	0.00556	CcSEcCtD
Theophylline—Anxiety—Progesterone—uterine cancer	0.000646	0.00556	CcSEcCtD
Theophylline—CYP1A2—renal system—uterine cancer	0.000638	0.00648	CbGeAlD
Theophylline—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000634	0.00545	CcSEcCtD
Theophylline—CYP1A1—renal system—uterine cancer	0.000629	0.00639	CbGeAlD
Theophylline—Ventricular arrhythmia—Doxorubicin—uterine cancer	0.000625	0.00537	CcSEcCtD
Theophylline—Anaphylactic shock—Progesterone—uterine cancer	0.000622	0.00535	CcSEcCtD
Theophylline—Albuminuria—Doxorubicin—uterine cancer	0.000619	0.00532	CcSEcCtD
Theophylline—Infection—Progesterone—uterine cancer	0.000618	0.00531	CcSEcCtD
Theophylline—Shock—Progesterone—uterine cancer	0.000612	0.00526	CcSEcCtD
Theophylline—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00061	0.00524	CcSEcCtD
Theophylline—Nervous system disorder—Progesterone—uterine cancer	0.00061	0.00524	CcSEcCtD
Theophylline—Tachycardia—Progesterone—uterine cancer	0.000607	0.00522	CcSEcCtD
Theophylline—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000598	0.00514	CcSEcCtD
Theophylline—Anorexia—Progesterone—uterine cancer	0.000593	0.0051	CcSEcCtD
Theophylline—CYP1A1—mammalian vulva—uterine cancer	0.000589	0.00598	CbGeAlD
Theophylline—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000586	0.00504	CcSEcCtD
Theophylline—Hypotension—Progesterone—uterine cancer	0.000581	0.00499	CcSEcCtD
Theophylline—Flushing—Dactinomycin—uterine cancer	0.000574	0.00494	CcSEcCtD
Theophylline—CYP2E1—renal system—uterine cancer	0.000574	0.00583	CbGeAlD
Theophylline—Extravasation—Epirubicin—uterine cancer	0.000573	0.00492	CcSEcCtD
Theophylline—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.000563	0.00484	CcSEcCtD
Theophylline—Insomnia—Progesterone—uterine cancer	0.000562	0.00483	CcSEcCtD
Theophylline—CYP1A1—uterus—uterine cancer	0.000561	0.0057	CbGeAlD
Theophylline—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00056	0.00481	CcSEcCtD
Theophylline—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000554	0.00477	CcSEcCtD
Theophylline—Ventricular extrasystoles—Epirubicin—uterine cancer	0.000553	0.00476	CcSEcCtD
Theophylline—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000552	0.00475	CcSEcCtD
Theophylline—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00055	0.00473	CcSEcCtD
Theophylline—Alopecia—Dactinomycin—uterine cancer	0.000546	0.0047	CcSEcCtD
Theophylline—CYP2C8—female reproductive system—uterine cancer	0.000546	0.00555	CbGeAlD
Theophylline—Decreased appetite—Progesterone—uterine cancer	0.00054	0.00465	CcSEcCtD
Theophylline—Hyperuricaemia—Epirubicin—uterine cancer	0.000539	0.00463	CcSEcCtD
Theophylline—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000537	0.00462	CcSEcCtD
Theophylline—Extravasation—Doxorubicin—uterine cancer	0.00053	0.00456	CcSEcCtD
Theophylline—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000526	0.00453	CcSEcCtD
Theophylline—Ventricular extrasystoles—Doxorubicin—uterine cancer	0.000512	0.0044	CcSEcCtD
Theophylline—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000509	0.00438	CcSEcCtD
Theophylline—Blood uric acid increased—Epirubicin—uterine cancer	0.000509	0.00437	CcSEcCtD
Theophylline—Gastrointestinal pain—Progesterone—uterine cancer	0.000508	0.00437	CcSEcCtD
Theophylline—CYP1A1—female reproductive system—uterine cancer	0.000504	0.00512	CbGeAlD
Theophylline—Hyperuricaemia—Doxorubicin—uterine cancer	0.000498	0.00429	CcSEcCtD
Theophylline—CYP2C8—vagina—uterine cancer	0.000494	0.00502	CbGeAlD
Theophylline—Urticaria—Progesterone—uterine cancer	0.000494	0.00425	CcSEcCtD
Theophylline—Dermatitis contact—Epirubicin—uterine cancer	0.000494	0.00425	CcSEcCtD
Theophylline—Body temperature increased—Progesterone—uterine cancer	0.000491	0.00423	CcSEcCtD
Theophylline—Abdominal pain—Progesterone—uterine cancer	0.000491	0.00423	CcSEcCtD
Theophylline—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00049	0.00421	CcSEcCtD
Theophylline—PDE4B—lymph node—uterine cancer	0.000487	0.00494	CbGeAlD
Theophylline—CYP2C9—female reproductive system—uterine cancer	0.000485	0.00493	CbGeAlD
Theophylline—Blood uric acid increased—Doxorubicin—uterine cancer	0.000471	0.00405	CcSEcCtD
Theophylline—CYP3A4—renal system—uterine cancer	0.000462	0.00469	CbGeAlD
Theophylline—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000461	0.00396	CcSEcCtD
Theophylline—CYP2E1—female reproductive system—uterine cancer	0.00046	0.00467	CbGeAlD
Theophylline—CYP1A1—female gonad—uterine cancer	0.000459	0.00466	CbGeAlD
Theophylline—Hypersensitivity—Progesterone—uterine cancer	0.000458	0.00394	CcSEcCtD
Theophylline—Dermatitis contact—Doxorubicin—uterine cancer	0.000457	0.00393	CcSEcCtD
Theophylline—Coma—Epirubicin—uterine cancer	0.000457	0.00393	CcSEcCtD
Theophylline—CYP1A1—vagina—uterine cancer	0.000456	0.00463	CbGeAlD
Theophylline—CYP2D6—renal system—uterine cancer	0.000454	0.00462	CbGeAlD
Theophylline—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000447	0.00385	CcSEcCtD
Theophylline—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000445	0.00383	CcSEcCtD
Theophylline—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000445	0.00383	CcSEcCtD
Theophylline—Pruritus—Progesterone—uterine cancer	0.00044	0.00378	CcSEcCtD
Theophylline—Infection—Dactinomycin—uterine cancer	0.000436	0.00375	CcSEcCtD
Theophylline—Diarrhoea—Progesterone—uterine cancer	0.000425	0.00366	CcSEcCtD
Theophylline—Coma—Doxorubicin—uterine cancer	0.000422	0.00363	CcSEcCtD
Theophylline—Phlebitis—Epirubicin—uterine cancer	0.000421	0.00362	CcSEcCtD
Theophylline—Anorexia—Dactinomycin—uterine cancer	0.000419	0.0036	CcSEcCtD
Theophylline—CYP1B1—lymph node—uterine cancer	0.000417	0.00424	CbGeAlD
Theophylline—Flushing—Etoposide—uterine cancer	0.000415	0.00357	CcSEcCtD
Theophylline—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000415	0.00357	CcSEcCtD
Theophylline—Dizziness—Progesterone—uterine cancer	0.000411	0.00353	CcSEcCtD
Theophylline—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000398	0.00343	CcSEcCtD
Theophylline—Alopecia—Etoposide—uterine cancer	0.000395	0.0034	CcSEcCtD
Theophylline—Vomiting—Progesterone—uterine cancer	0.000395	0.0034	CcSEcCtD
Theophylline—Rash—Progesterone—uterine cancer	0.000392	0.00337	CcSEcCtD
Theophylline—Dermatitis—Progesterone—uterine cancer	0.000392	0.00337	CcSEcCtD
Theophylline—Phlebitis—Doxorubicin—uterine cancer	0.000389	0.00335	CcSEcCtD
Theophylline—Headache—Progesterone—uterine cancer	0.000389	0.00335	CcSEcCtD
Theophylline—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000385	0.00331	CcSEcCtD
Theophylline—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000384	0.0033	CcSEcCtD
Theophylline—Decreased appetite—Dactinomycin—uterine cancer	0.000382	0.00328	CcSEcCtD
Theophylline—Anaphylactoid reaction—Epirubicin—uterine cancer	0.000375	0.00322	CcSEcCtD
Theophylline—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000372	0.0032	CcSEcCtD
Theophylline—CYP3A4—female reproductive system—uterine cancer	0.00037	0.00376	CbGeAlD
Theophylline—Nausea—Progesterone—uterine cancer	0.000369	0.00317	CcSEcCtD
Theophylline—CYP2D6—female reproductive system—uterine cancer	0.000364	0.0037	CbGeAlD
Theophylline—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000359	0.00309	CcSEcCtD
Theophylline—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000358	0.00308	CcSEcCtD
Theophylline—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000356	0.00306	CcSEcCtD
Theophylline—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000355	0.00305	CcSEcCtD
Theophylline—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000355	0.00305	CcSEcCtD
Theophylline—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000353	0.00303	CcSEcCtD
Theophylline—Abdominal pain—Dactinomycin—uterine cancer	0.000347	0.00299	CcSEcCtD
Theophylline—Body temperature increased—Dactinomycin—uterine cancer	0.000347	0.00299	CcSEcCtD
Theophylline—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000347	0.00298	CcSEcCtD
Theophylline—Convulsion—Etoposide—uterine cancer	0.000338	0.0029	CcSEcCtD
Theophylline—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000335	0.00288	CcSEcCtD
Theophylline—Abdominal pain upper—Epirubicin—uterine cancer	0.000331	0.00285	CcSEcCtD
Theophylline—CYP2D6—female gonad—uterine cancer	0.000331	0.00337	CbGeAlD
Theophylline—Hypokalaemia—Epirubicin—uterine cancer	0.00033	0.00284	CcSEcCtD
Theophylline—Hypersensitivity—Dactinomycin—uterine cancer	0.000324	0.00278	CcSEcCtD
Theophylline—Anaphylactic shock—Etoposide—uterine cancer	0.000318	0.00273	CcSEcCtD
Theophylline—Infection—Etoposide—uterine cancer	0.000316	0.00272	CcSEcCtD
Theophylline—Tachycardia—Etoposide—uterine cancer	0.00031	0.00267	CcSEcCtD
Theophylline—Abdominal pain upper—Doxorubicin—uterine cancer	0.000306	0.00264	CcSEcCtD
Theophylline—Hypokalaemia—Doxorubicin—uterine cancer	0.000305	0.00263	CcSEcCtD
Theophylline—Anorexia—Etoposide—uterine cancer	0.000303	0.00261	CcSEcCtD
Theophylline—Diarrhoea—Dactinomycin—uterine cancer	0.000301	0.00258	CcSEcCtD
Theophylline—Hypotension—Etoposide—uterine cancer	0.000297	0.00256	CcSEcCtD
Theophylline—CYP1A1—lymph node—uterine cancer	0.000295	0.003	CbGeAlD
Theophylline—Hyperglycaemia—Epirubicin—uterine cancer	0.000283	0.00243	CcSEcCtD
Theophylline—Vomiting—Dactinomycin—uterine cancer	0.000279	0.0024	CcSEcCtD
Theophylline—Rash—Dactinomycin—uterine cancer	0.000277	0.00238	CcSEcCtD
Theophylline—Decreased appetite—Etoposide—uterine cancer	0.000276	0.00238	CcSEcCtD
Theophylline—Haematuria—Epirubicin—uterine cancer	0.000266	0.00229	CcSEcCtD
Theophylline—Hyperglycaemia—Doxorubicin—uterine cancer	0.000262	0.00225	CcSEcCtD
Theophylline—Nausea—Dactinomycin—uterine cancer	0.000261	0.00224	CcSEcCtD
Theophylline—Gastrointestinal pain—Etoposide—uterine cancer	0.00026	0.00224	CcSEcCtD
Theophylline—Urticaria—Etoposide—uterine cancer	0.000253	0.00217	CcSEcCtD
Theophylline—Abdominal pain—Etoposide—uterine cancer	0.000251	0.00216	CcSEcCtD
Theophylline—Body temperature increased—Etoposide—uterine cancer	0.000251	0.00216	CcSEcCtD
Theophylline—Haematuria—Doxorubicin—uterine cancer	0.000247	0.00212	CcSEcCtD
Theophylline—Hypersensitivity—Etoposide—uterine cancer	0.000234	0.00201	CcSEcCtD
Theophylline—Flushing—Epirubicin—uterine cancer	0.000233	0.002	CcSEcCtD
Theophylline—Pruritus—Etoposide—uterine cancer	0.000225	0.00193	CcSEcCtD
Theophylline—Arrhythmia—Epirubicin—uterine cancer	0.000224	0.00193	CcSEcCtD
Theophylline—Alopecia—Epirubicin—uterine cancer	0.000222	0.00191	CcSEcCtD
Theophylline—Diarrhoea—Etoposide—uterine cancer	0.000218	0.00187	CcSEcCtD
Theophylline—Flushing—Doxorubicin—uterine cancer	0.000215	0.00185	CcSEcCtD
Theophylline—Tension—Epirubicin—uterine cancer	0.000214	0.00184	CcSEcCtD
Theophylline—Nervousness—Epirubicin—uterine cancer	0.000212	0.00182	CcSEcCtD
Theophylline—Dizziness—Etoposide—uterine cancer	0.00021	0.00181	CcSEcCtD
Theophylline—Arrhythmia—Doxorubicin—uterine cancer	0.000207	0.00178	CcSEcCtD
Theophylline—Alopecia—Doxorubicin—uterine cancer	0.000205	0.00176	CcSEcCtD
Theophylline—Vomiting—Etoposide—uterine cancer	0.000202	0.00174	CcSEcCtD
Theophylline—Agitation—Epirubicin—uterine cancer	0.000201	0.00173	CcSEcCtD
Theophylline—Rash—Etoposide—uterine cancer	0.0002	0.00172	CcSEcCtD
Theophylline—Dermatitis—Etoposide—uterine cancer	0.0002	0.00172	CcSEcCtD
Theophylline—Headache—Etoposide—uterine cancer	0.000199	0.00171	CcSEcCtD
Theophylline—Tension—Doxorubicin—uterine cancer	0.000198	0.00171	CcSEcCtD
Theophylline—Nervousness—Doxorubicin—uterine cancer	0.000196	0.00169	CcSEcCtD
Theophylline—Palpitations—Epirubicin—uterine cancer	0.000193	0.00166	CcSEcCtD
Theophylline—Convulsion—Epirubicin—uterine cancer	0.000189	0.00163	CcSEcCtD
Theophylline—Nausea—Etoposide—uterine cancer	0.000189	0.00162	CcSEcCtD
Theophylline—Agitation—Doxorubicin—uterine cancer	0.000186	0.0016	CcSEcCtD
Theophylline—Anxiety—Epirubicin—uterine cancer	0.000185	0.00159	CcSEcCtD
Theophylline—Palpitations—Doxorubicin—uterine cancer	0.000179	0.00154	CcSEcCtD
Theophylline—Anaphylactic shock—Epirubicin—uterine cancer	0.000178	0.00153	CcSEcCtD
Theophylline—Infection—Epirubicin—uterine cancer	0.000177	0.00152	CcSEcCtD
Theophylline—Shock—Epirubicin—uterine cancer	0.000175	0.00151	CcSEcCtD
Theophylline—Convulsion—Doxorubicin—uterine cancer	0.000175	0.00151	CcSEcCtD
Theophylline—Nervous system disorder—Epirubicin—uterine cancer	0.000175	0.0015	CcSEcCtD
Theophylline—Tachycardia—Epirubicin—uterine cancer	0.000174	0.0015	CcSEcCtD
Theophylline—Anxiety—Doxorubicin—uterine cancer	0.000171	0.00147	CcSEcCtD
Theophylline—Anorexia—Epirubicin—uterine cancer	0.00017	0.00146	CcSEcCtD
Theophylline—Hypotension—Epirubicin—uterine cancer	0.000167	0.00143	CcSEcCtD
Theophylline—Anaphylactic shock—Doxorubicin—uterine cancer	0.000165	0.00142	CcSEcCtD
Theophylline—Infection—Doxorubicin—uterine cancer	0.000164	0.00141	CcSEcCtD
Theophylline—Shock—Doxorubicin—uterine cancer	0.000162	0.0014	CcSEcCtD
Theophylline—Nervous system disorder—Doxorubicin—uterine cancer	0.000162	0.00139	CcSEcCtD
Theophylline—Insomnia—Epirubicin—uterine cancer	0.000161	0.00139	CcSEcCtD
Theophylline—Tachycardia—Doxorubicin—uterine cancer	0.000161	0.00138	CcSEcCtD
Theophylline—Anorexia—Doxorubicin—uterine cancer	0.000157	0.00135	CcSEcCtD
Theophylline—Decreased appetite—Epirubicin—uterine cancer	0.000155	0.00133	CcSEcCtD
Theophylline—Hypotension—Doxorubicin—uterine cancer	0.000154	0.00133	CcSEcCtD
Theophylline—Insomnia—Doxorubicin—uterine cancer	0.000149	0.00128	CcSEcCtD
Theophylline—Gastrointestinal pain—Epirubicin—uterine cancer	0.000146	0.00125	CcSEcCtD
Theophylline—Decreased appetite—Doxorubicin—uterine cancer	0.000143	0.00123	CcSEcCtD
Theophylline—Urticaria—Epirubicin—uterine cancer	0.000142	0.00122	CcSEcCtD
Theophylline—Abdominal pain—Epirubicin—uterine cancer	0.000141	0.00121	CcSEcCtD
Theophylline—Body temperature increased—Epirubicin—uterine cancer	0.000141	0.00121	CcSEcCtD
Theophylline—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000135	0.00116	CcSEcCtD
Theophylline—Hypersensitivity—Epirubicin—uterine cancer	0.000131	0.00113	CcSEcCtD
Theophylline—Urticaria—Doxorubicin—uterine cancer	0.000131	0.00113	CcSEcCtD
Theophylline—Body temperature increased—Doxorubicin—uterine cancer	0.00013	0.00112	CcSEcCtD
Theophylline—Abdominal pain—Doxorubicin—uterine cancer	0.00013	0.00112	CcSEcCtD
Theophylline—Pruritus—Epirubicin—uterine cancer	0.000126	0.00108	CcSEcCtD
Theophylline—Diarrhoea—Epirubicin—uterine cancer	0.000122	0.00105	CcSEcCtD
Theophylline—Hypersensitivity—Doxorubicin—uterine cancer	0.000122	0.00104	CcSEcCtD
Theophylline—Dizziness—Epirubicin—uterine cancer	0.000118	0.00101	CcSEcCtD
Theophylline—Pruritus—Doxorubicin—uterine cancer	0.000117	0.001	CcSEcCtD
Theophylline—Vomiting—Epirubicin—uterine cancer	0.000113	0.000975	CcSEcCtD
Theophylline—Diarrhoea—Doxorubicin—uterine cancer	0.000113	0.00097	CcSEcCtD
Theophylline—Rash—Epirubicin—uterine cancer	0.000112	0.000966	CcSEcCtD
Theophylline—Dermatitis—Epirubicin—uterine cancer	0.000112	0.000966	CcSEcCtD
Theophylline—Headache—Epirubicin—uterine cancer	0.000112	0.00096	CcSEcCtD
Theophylline—Dizziness—Doxorubicin—uterine cancer	0.000109	0.000938	CcSEcCtD
Theophylline—Nausea—Epirubicin—uterine cancer	0.000106	0.00091	CcSEcCtD
Theophylline—Vomiting—Doxorubicin—uterine cancer	0.000105	0.000902	CcSEcCtD
Theophylline—Rash—Doxorubicin—uterine cancer	0.000104	0.000894	CcSEcCtD
Theophylline—Dermatitis—Doxorubicin—uterine cancer	0.000104	0.000893	CcSEcCtD
Theophylline—Headache—Doxorubicin—uterine cancer	0.000103	0.000888	CcSEcCtD
Theophylline—Nausea—Doxorubicin—uterine cancer	9.8e-05	0.000842	CcSEcCtD
Theophylline—CYP1A1—Metabolism—AKR1C3—uterine cancer	1.67e-05	0.000149	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—ESR1—uterine cancer	1.66e-05	0.000149	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—EP300—uterine cancer	1.66e-05	0.000148	CbGpPWpGaD
Theophylline—PDE3B—GPCR downstream signaling—AKT1—uterine cancer	1.65e-05	0.000148	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CDKN1B—uterine cancer	1.64e-05	0.000147	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—ERBB2—uterine cancer	1.64e-05	0.000147	CbGpPWpGaD
Theophylline—HDAC2—Disease—CTNNB1—uterine cancer	1.64e-05	0.000147	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—CTNNB1—uterine cancer	1.63e-05	0.000145	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.63e-05	0.000145	CbGpPWpGaD
Theophylline—PDE4D—GPCR downstream signaling—AKT1—uterine cancer	1.63e-05	0.000145	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.62e-05	0.000144	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.61e-05	0.000144	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—PIK3CA—uterine cancer	1.61e-05	0.000144	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CXCL8—uterine cancer	1.6e-05	0.000143	CbGpPWpGaD
Theophylline—HDAC2—Disease—PTEN—uterine cancer	1.6e-05	0.000143	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—PIK3CA—uterine cancer	1.59e-05	0.000142	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—HRAS—uterine cancer	1.59e-05	0.000142	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—PTEN—uterine cancer	1.59e-05	0.000142	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—MTHFR—uterine cancer	1.58e-05	0.000141	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—ERBB2—uterine cancer	1.58e-05	0.000141	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—CTNNB1—uterine cancer	1.58e-05	0.000141	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CCL2—uterine cancer	1.58e-05	0.000141	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—NRAS—uterine cancer	1.57e-05	0.000141	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—VEGFA—uterine cancer	1.57e-05	0.00014	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CDKN1B—uterine cancer	1.57e-05	0.00014	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—ERBB2—uterine cancer	1.56e-05	0.00014	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CXCL8—uterine cancer	1.56e-05	0.000139	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—CTNNB1—uterine cancer	1.55e-05	0.000139	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—NRAS—uterine cancer	1.55e-05	0.000139	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—HRAS—uterine cancer	1.55e-05	0.000138	CbGpPWpGaD
Theophylline—ADORA2B—Signaling by GPCR—AKT1—uterine cancer	1.55e-05	0.000138	CbGpPWpGaD
Theophylline—PDE4A—GPCR downstream signaling—AKT1—uterine cancer	1.55e-05	0.000138	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PTEN—uterine cancer	1.54e-05	0.000137	CbGpPWpGaD
Theophylline—ADA—Metabolism—PIK3CA—uterine cancer	1.53e-05	0.000137	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.53e-05	0.000136	CbGpPWpGaD
Theophylline—HDAC2—Disease—EP300—uterine cancer	1.53e-05	0.000136	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CDKN1B—uterine cancer	1.52e-05	0.000136	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PTEN—uterine cancer	1.51e-05	0.000135	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—EP300—uterine cancer	1.51e-05	0.000135	CbGpPWpGaD
Theophylline—PDE3A—GPCR downstream signaling—AKT1—uterine cancer	1.51e-05	0.000135	CbGpPWpGaD
Theophylline—PDE3B—Signaling by GPCR—AKT1—uterine cancer	1.5e-05	0.000134	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CXCL8—uterine cancer	1.5e-05	0.000134	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—HRAS—uterine cancer	1.49e-05	0.000133	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CXCL8—uterine cancer	1.48e-05	0.000132	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—CTNNB1—uterine cancer	1.48e-05	0.000132	CbGpPWpGaD
Theophylline—PDE4D—Signaling by GPCR—AKT1—uterine cancer	1.48e-05	0.000132	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—POLD1—uterine cancer	1.47e-05	0.000132	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—HRAS—uterine cancer	1.47e-05	0.000132	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—EP300—uterine cancer	1.47e-05	0.000131	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CDKN1B—uterine cancer	1.47e-05	0.000131	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CCL2—uterine cancer	1.47e-05	0.000131	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—RRM2—uterine cancer	1.45e-05	0.00013	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.45e-05	0.00013	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—STAR—uterine cancer	1.45e-05	0.00013	CbGpPWpGaD
Theophylline—ADORA1—GPCR downstream signaling—AKT1—uterine cancer	1.45e-05	0.00013	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CDKN1B—uterine cancer	1.45e-05	0.000129	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—EP300—uterine cancer	1.44e-05	0.000129	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PTEN—uterine cancer	1.44e-05	0.000129	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—RRM2—uterine cancer	1.44e-05	0.000129	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—CTNNB1—uterine cancer	1.44e-05	0.000128	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—VEGFA—uterine cancer	1.43e-05	0.000128	CbGpPWpGaD
Theophylline—PDE4B—GPCR downstream signaling—AKT1—uterine cancer	1.43e-05	0.000128	CbGpPWpGaD
Theophylline—HDAC2—Disease—NRAS—uterine cancer	1.43e-05	0.000128	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—NRAS—uterine cancer	1.42e-05	0.000126	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—DCN—uterine cancer	1.41e-05	0.000126	CbGpPWpGaD
Theophylline—PDE4A—Signaling by GPCR—AKT1—uterine cancer	1.41e-05	0.000126	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PTEN—uterine cancer	1.4e-05	0.000125	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—DCN—uterine cancer	1.4e-05	0.000125	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.4e-05	0.000125	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—VEGFA—uterine cancer	1.39e-05	0.000124	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—CTNNB1—uterine cancer	1.38e-05	0.000124	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.38e-05	0.000123	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—STK11—uterine cancer	1.38e-05	0.000123	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—CYP19A1—uterine cancer	1.38e-05	0.000123	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—EP300—uterine cancer	1.37e-05	0.000123	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—NRAS—uterine cancer	1.37e-05	0.000123	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—PIK3CA—uterine cancer	1.37e-05	0.000122	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—CTNNB1—uterine cancer	1.37e-05	0.000122	CbGpPWpGaD
Theophylline—PDE3A—Signaling by GPCR—AKT1—uterine cancer	1.37e-05	0.000122	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—VEGFA—uterine cancer	1.37e-05	0.000122	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—KRAS—uterine cancer	1.35e-05	0.000121	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—NRAS—uterine cancer	1.35e-05	0.000121	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PTEN—uterine cancer	1.35e-05	0.000121	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—EP300—uterine cancer	1.34e-05	0.000119	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—KRAS—uterine cancer	1.34e-05	0.000119	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PTEN—uterine cancer	1.33e-05	0.000119	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.33e-05	0.000119	CbGpPWpGaD
Theophylline—ADORA1—Signaling by GPCR—AKT1—uterine cancer	1.32e-05	0.000118	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.32e-05	0.000118	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—ERBB2—uterine cancer	1.31e-05	0.000117	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—VEGFA—uterine cancer	1.3e-05	0.000116	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—AKT1—uterine cancer	1.3e-05	0.000116	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—CYP19A1—uterine cancer	1.3e-05	0.000116	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—STK11—uterine cancer	1.3e-05	0.000116	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—EP300—uterine cancer	1.29e-05	0.000115	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—NRAS—uterine cancer	1.29e-05	0.000115	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—EP300—uterine cancer	1.27e-05	0.000114	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—VEGFA—uterine cancer	1.27e-05	0.000113	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.25e-05	0.000112	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—NRAS—uterine cancer	1.25e-05	0.000112	CbGpPWpGaD
Theophylline—ADA—Metabolism—AKT1—uterine cancer	1.25e-05	0.000112	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CXCL8—uterine cancer	1.25e-05	0.000111	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—PIK3CA—uterine cancer	1.24e-05	0.000111	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.24e-05	0.000111	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—RRM2—uterine cancer	1.23e-05	0.00011	CbGpPWpGaD
Theophylline—HDAC2—Disease—KRAS—uterine cancer	1.23e-05	0.00011	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—PIK3CA—uterine cancer	1.23e-05	0.00011	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—ERBB2—uterine cancer	1.22e-05	0.000109	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—VEGFA—uterine cancer	1.22e-05	0.000109	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—KRAS—uterine cancer	1.22e-05	0.000109	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.22e-05	0.000109	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CDKN1B—uterine cancer	1.22e-05	0.000109	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—VEGFA—uterine cancer	1.2e-05	0.000108	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—NRAS—uterine cancer	1.2e-05	0.000108	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—DCN—uterine cancer	1.19e-05	0.000107	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—NRAS—uterine cancer	1.19e-05	0.000106	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.19e-05	0.000106	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—STK11—uterine cancer	1.19e-05	0.000106	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—TP53—uterine cancer	1.19e-05	0.000106	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—KRAS—uterine cancer	1.18e-05	0.000106	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—KRAS—uterine cancer	1.16e-05	0.000104	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.16e-05	0.000104	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CXCL8—uterine cancer	1.16e-05	0.000104	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—HRAS—uterine cancer	1.15e-05	0.000103	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CTNNB1—uterine cancer	1.15e-05	0.000103	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—POLD1—uterine cancer	1.14e-05	0.000102	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—HRAS—uterine cancer	1.14e-05	0.000101	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CDKN1B—uterine cancer	1.13e-05	0.000101	CbGpPWpGaD
Theophylline—HDAC2—Disease—PIK3CA—uterine cancer	1.13e-05	0.000101	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.12e-05	0.0001	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PTEN—uterine cancer	1.12e-05	0.0001	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—PIK3CA—uterine cancer	1.12e-05	0.0001	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—AKT1—uterine cancer	1.12e-05	0.0001	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.12e-05	9.97e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—KRAS—uterine cancer	1.11e-05	9.89e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—PIK3CA—uterine cancer	1.09e-05	9.7e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—TP53—uterine cancer	1.08e-05	9.68e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—KRAS—uterine cancer	1.08e-05	9.62e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CTNNB1—uterine cancer	1.07e-05	9.55e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—EP300—uterine cancer	1.07e-05	9.55e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—PIK3CA—uterine cancer	1.07e-05	9.54e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.06e-05	9.51e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.06e-05	9.51e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.06e-05	9.49e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TP53—uterine cancer	1.05e-05	9.38e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—HRAS—uterine cancer	1.04e-05	9.33e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PTEN—uterine cancer	1.04e-05	9.31e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—KRAS—uterine cancer	1.04e-05	9.26e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—HRAS—uterine cancer	1.04e-05	9.25e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—MTHFR—uterine cancer	1.03e-05	9.24e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TP53—uterine cancer	1.03e-05	9.23e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—KRAS—uterine cancer	1.02e-05	9.15e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—PIK3CA—uterine cancer	1.02e-05	9.08e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—AKT1—uterine cancer	1.02e-05	9.08e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VEGFA—uterine cancer	1.01e-05	9.04e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—HRAS—uterine cancer	1e-05	8.97e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—AKT1—uterine cancer	1e-05	8.95e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—NRAS—uterine cancer	1e-05	8.93e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—EP300—uterine cancer	9.94e-06	8.88e-05	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—AKT1—uterine cancer	9.93e-06	8.87e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—PIK3CA—uterine cancer	9.89e-06	8.83e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—HRAS—uterine cancer	9.88e-06	8.83e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TP53—uterine cancer	9.84e-06	8.79e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CYP19A1—uterine cancer	9.77e-06	8.72e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—STK11—uterine cancer	9.77e-06	8.72e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—MTHFR—uterine cancer	9.75e-06	8.71e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—STK11—uterine cancer	9.68e-06	8.65e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CYP19A1—uterine cancer	9.68e-06	8.65e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TP53—uterine cancer	9.57e-06	8.55e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—PIK3CA—uterine cancer	9.52e-06	8.5e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—RRM2—uterine cancer	9.49e-06	8.48e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VEGFA—uterine cancer	9.41e-06	8.41e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—PIK3CA—uterine cancer	9.41e-06	8.4e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—HRAS—uterine cancer	9.41e-06	8.4e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—NRAS—uterine cancer	9.3e-06	8.3e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—AKT1—uterine cancer	9.22e-06	8.24e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—DCN—uterine cancer	9.21e-06	8.23e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TP53—uterine cancer	9.21e-06	8.23e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—HRAS—uterine cancer	9.15e-06	8.17e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—AKT1—uterine cancer	9.15e-06	8.17e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TP53—uterine cancer	9.1e-06	8.13e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.09e-06	8.12e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—MTHFR—uterine cancer	8.94e-06	7.98e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—AKT1—uterine cancer	8.87e-06	7.92e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—HRAS—uterine cancer	8.81e-06	7.87e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTEN—uterine cancer	8.81e-06	7.87e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—AKT1—uterine cancer	8.73e-06	7.79e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—HRAS—uterine cancer	8.7e-06	7.77e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP11A1—uterine cancer	8.68e-06	7.75e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.67e-06	7.74e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—KRAS—uterine cancer	8.61e-06	7.69e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.59e-06	7.67e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—EP300—uterine cancer	8.4e-06	7.5e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—AKT1—uterine cancer	8.31e-06	7.42e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—STK11—uterine cancer	8.27e-06	7.39e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CYP19A1—uterine cancer	8.27e-06	7.39e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKR1C3—uterine cancer	8.2e-06	7.32e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—AKT1—uterine cancer	8.08e-06	7.22e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—KRAS—uterine cancer	8e-06	7.15e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—PIK3CA—uterine cancer	7.91e-06	7.06e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.88e-06	7.04e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—AKT1—uterine cancer	7.78e-06	6.95e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.77e-06	6.94e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—AKT1—uterine cancer	7.69e-06	6.86e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TP53—uterine cancer	7.65e-06	6.83e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.41e-06	6.62e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—PIK3CA—uterine cancer	7.35e-06	6.57e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—MTHFR—uterine cancer	7.34e-06	6.56e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—HRAS—uterine cancer	7.32e-06	6.53e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—MTHFR—uterine cancer	7.28e-06	6.5e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TP53—uterine cancer	7.11e-06	6.35e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—HRAS—uterine cancer	6.8e-06	6.07e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—AKT1—uterine cancer	6.46e-06	5.77e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.41e-06	5.73e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—STK11—uterine cancer	6.38e-06	5.7e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP19A1—uterine cancer	6.38e-06	5.7e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—MTHFR—uterine cancer	6.22e-06	5.55e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PIK3CA—uterine cancer	6.21e-06	5.55e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—AKT1—uterine cancer	6e-06	5.36e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTEN—uterine cancer	5.75e-06	5.14e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—EP300—uterine cancer	5.49e-06	4.9e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.48e-06	4.89e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTEN—uterine cancer	5.42e-06	4.84e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—EP300—uterine cancer	5.17e-06	4.62e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—AKT1—uterine cancer	5.08e-06	4.53e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTEN—uterine cancer	4.97e-06	4.44e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—MTHFR—uterine cancer	4.8e-06	4.29e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—EP300—uterine cancer	4.74e-06	4.24e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTEN—uterine cancer	4.08e-06	3.65e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CA—uterine cancer	4.06e-06	3.63e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTEN—uterine cancer	4.05e-06	3.62e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—EP300—uterine cancer	3.89e-06	3.48e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—EP300—uterine cancer	3.86e-06	3.45e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CA—uterine cancer	3.83e-06	3.42e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.51e-06	3.13e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTEN—uterine cancer	3.46e-06	3.09e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—AKT1—uterine cancer	3.32e-06	2.96e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—EP300—uterine cancer	3.3e-06	2.95e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—AKT1—uterine cancer	3.13e-06	2.79e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.88e-06	2.57e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—AKT1—uterine cancer	2.87e-06	2.56e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.86e-06	2.55e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTEN—uterine cancer	2.67e-06	2.38e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—EP300—uterine cancer	2.55e-06	2.27e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.44e-06	2.18e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AKT1—uterine cancer	2.35e-06	2.1e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AKT1—uterine cancer	2.33e-06	2.08e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AKT1—uterine cancer	1.99e-06	1.78e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.88e-06	1.68e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKT1—uterine cancer	1.54e-06	1.37e-05	CbGpPWpGaD
